US Stocks Move | Eli Lilly (LLY.US) rises over 7% as Q2 revenue surges 48% year-on-year and full-year outlook is raised

According to Zhitong Finance APP, on Wednesday, Eli Lilly (LLY.US) rose more than 7% to $1,197.12. In terms of news, on August 5, Eli Lilly announced its financial report for the second quarter of 2026. The company achieved revenue of $22.97 billion, a year-on-year increase of 48%, exceeding the market expectation of $20.59 billion; adjusted earnings per share (Non-GAAP EPS) reached $8.38, a year-on-year increase of 33%, far surpassing analysts' expected $6.31.